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ABSTRACT
Objective: The aim of this trial was to determine whether Flotrac Vigileo™ (FV™) 
provides a reliable representation of the hemodynamic state of a cardiac surgical patient 
population when compared to pulmonary artery catheter (PAC) and echocardiography 
in the peril‑operative period.
Design: This was a prospective observational trial comparing perioperative hemodynamic 
states using transesophageal echocardiography (TEE), transthoracic echocardiography 
(TTE), FV™ and PAC during and post cardiothoracic surgery.
Setting: Tertiary regional hospital Intensive Care Unit (ICU).
Participants: 50 consecutive adult cardiothoracic patients with written consent provided.
Intervention: Comparison of the perioperative hemodynamic states using echocardiography, 
FV™ and PAC was performed. Evaluation of the hemodynamic state (HDS) was performed 
using TEE, TTE, PAC and FV™ during and after cardiac surgery. Data were compared 
between the three hemodynamic assessment modalities. 
Main Outcome Measure: Predicted hemodynamic state.
Results: FV™ and PAC were shown to correlate poorly with TEE/TTE assessment of 
the hemodynamic state. Both PAC and FV™ showed significant discordance with 
echocardiographic assessment of the hemodynamic state.
Conclusions: In this trial, FV™ and PAC were shown to agree poorly with TTE/TEE 
assessment of the HDS in an adult cardiothoracic population. Agreement between the FV™ 
and PAC was also poor. Caution is recommended in interpreting isolated hemodynamic 
monitoring data. All hemodynamic monitoring devices have inherent sources of error. 
Caution is advised in interpreting any single device or measurement as a gold standard. 
We suggest that hemodynamic measuring devices such as FV™/ 
PAC may act as triggers for a global hemodynamic assessment 
including consideration of TTE/TEE.
Key Words: Anesthesia, cardiaothoracic, hemodynamic 
monitoring, intensive care
INTRODUCTION
Invasive hemodynamic monitoring is commonly utilized 
in the perioperative care of cardiac surgery patients, and 
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is an essential component of decision‑making in relation 
to the hemodynamic state (HDS).[1] The pulmonary artery 
catheter (PAC) is used to measure cardiac output (CO) 
and systemic vascular resistance (SVR) to evaluate the 
hemodynamic status of a patient.[2] PACS have been in use 
for 30 years, despite equivocal evidence as to their utility in 
an intensive care environment.[3] PACs are associated with 
adverse events, including increased incidence of arrhythmias, 
providing false readings under certain conditions, and 
pulmonary artery rupture and death.[4] Noninvasive CO 
monitoring devices have some desirable properties but have 
been found to be variably reliable.[5‑8] Several recent trials 
have evaluated the efficacy of arterial waveform analysis 
monitoring using the FloTrac/Vigileo™ (FV™) (Edwards 
Lifesciences, Irvine, CA, USA) monitoring system.[9‑13] FV™ 
data are extrapolated from the arterial pressure waveform 
after correction for body height and weight, age, and gender. 
Several iterations of FV™ software have made the device 
increasingly reliable.[10] The majority of trials have sought to 
validate the measurements of the FV™ compared to a gold 
standard (e.g., PAC, transthoracic echocardiography [TTE]). 
To safely manage patients during and after cardiac surgery, 
it is important to have reliable and regular assessments of 
the HDS.[14] The aim of this study was to determine whether 
FV™ provides a reliable representation of the patients’ 
HDS when compared to PAC and echocardiography in the 
intra‑ and post‑operative period.
METHODS
Patients and setting
University Hospital Geelong is a tertiary regional hospital 
with a level 3 Intensive Care Unit (ICU), and performs 
over 400 cardiac surgeries each year. The current method 
of hemodynamic monitoring during and after surgery 
includes a PAC in combination with perioperative 
transesophageal echocardiography (TEE).
Methods
After the Local Human Research Ethics Committee 
approval and obtaining prior written informed consent, 
fifty adult patients scheduled for elective or semi‑urgent 
coronary artery bypass grafting (CABG) and or valve 
replacement/repair with cardiopulmonary bypass were 
included in the trial. Exclusion criteria were the presence 
of atrial fibrillation at the time of consent, planned 
intra‑aortic balloon pump placement, and severe valvular 
dysfunction. FV™ monitors were loaned by Edwards 
Lifesciences for the duration of the trial; however, 
consumables were funded independently. Edwards 
Lifesciences were not involved in trial design or the trial 
itself, including data analysis or write‑up.
Routine intra‑ and post‑operative management
Anesthetic and postoperative management followed 
institutional clinical guidelines for intra‑ and post‑operative 
care. After induction and intubation, a PAC (7.5 F, 
Edwards, Irvine, CA, USA) was placed through the 
internal jugular vein and correct positioning confirmed by 
pulmonary artery pressure waveform analysis. The PAC 
was then connected to an Edwards Vigilance II™ monitor 
for continuous CO monitoring. FV™ 3rd generation 
software was utilized. After radial artery cannulation, the 
arterial pressure waveform was confirmed as accurate 
and the pressure monitoring set and FV™ monitor were 
connected. Patients’ height and weight were entered 
into the Vigilance II™ and FV™ monitors. All pressure 
transducers were referenced to the mid‑axillary line and 
zeroed before recording of hemodynamic parameters.
Measurement of transthoracic echocardiography/
transesophageal echocardiography hemodynamic 
parameters
The initial two TEE studies were performed in the 
operating theater as the part of routine cardiac assessment 
during surgery. An initial TEE was performed prebypass 
(TEE 1) and a 2nd postbypass (TEE 2). At these time 
points central venous pressure (CVP), cardiac index (CI) 
and SVR index (SVRI) from the PAC and FV™ were 
documented by an anesthetist. Postoperative TTE/TEE 
was performed after transfer to the ICU, when the patient 
was hemodynamically stable and able to be positioned 
on their left side. At the time of the TTE/TEE, CVP, CI 
and SVRI from the PAC and FV™ were documented by 
a registered nurse. In addition, after admission to ICU, 
CI, and SVRI from the FV™ were documented as the part 
of the trial until the PAC was removed. CVP was used in 
preference to pulmonary artery wedge pressure (PAWP) as 
PAWP is potentially hazardous and not routinely recorded 
in this cardiothoracic center. Hemodynamic parameters 
were collected and documented by an anesthetist 
or registered nurse with a specialty postgraduate 
qualification. TTE/TEE was performed by cardiac 
anesthetists/intensivists holding a qualification in critical 
care echocardiography (PTEeXAM®/H.A.R.T.scan®/
Postgraduate Diploma in Clinical Ultrasound [PGDipCU]). 
Echocardiographic views and measurements were 
based on standard practice and commonly measured 
criteria during rapid assessment scanning protocols. 
Echocardiograms were classified into one of four HDSs 
using an algorithm based on modified H.A.R.T.scan® 
criteria [Appendix 1].[15,16] Criteria included measurements 
of ventricular volume, systolic function, and interatrial 
septal motion. Left ventricular (LV) function was based 
on the measurement of fractional shortening (FS) or area 
change while the filling  state was assessed using the LV 
end‑diastolic diameter or area (depending on TTE or TEE). 
A vasodilated state was denoted by the echocardiographic 
findings of a hyperdynamic state (FS >44%) in the absence 
of criteria for “empty.” Using proprietary instructions 
on monitoring interpretation, measurements from 
the PAC (including CVP)[17‑19] and FV™ were used to 
determine one of these four hemodynamic states for 
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each device. Where HDSs were overlapping, the cardiac 
state was deemed to be the primary state (e.g., primary 
systolic failure [PSF] vs. vasodilated). All TTE/TEE studies 
were reviewed independently for agreement by a cardiac 
anesthetist and intensivist holding echocardiography 
qualifications (PTEeXAM®/PGDipCU).
Blinding
Vigilance II™ and Vigileo™ monitor screens were 
obscured at the time the anesthetist/intensivist was 
performing the TTE/TEE. Hemodynamic parameters 
were documented at the time the TTE/TEE was performed 
or immediately after.
Data
Each patient was allocated a number and patient 
identifiers were removed. Baseline data was collected 
for each patient. This included age, gender, procedure 
performed, length of ICU stay, APACHE II score, 
and duration of mechanical ventilation. TTE/TEE and 
corresponding hemodynamic data for the time points 
described above were entered into the patient database.
Statistical analysis
Continuous normally distributed variables were 
presented as means (standard deviation), whereas 
nonnormally distributed variables were reported as 
medians (interquartile range). Comparison was performed 
between multiple devices (TTE/TEE/PAC/FV™) for 4 HDSs, 
with agreement reported using kappa concordance.
RESULTS
Demographics
Table 1 demonstrates patient characteristics. The 
cohort was predominantly male (86%), with the most 
frequent procedure CABG (58%) then aortic valve 
replacement (24%) surgery. The mean age was 68.5 years.
Hemodynamic states
Table 2 describes the HDS indicated by echocardiography. 
The majority of patients were classified as having an 
empty or normal HDS at the first echocardiogram (TEE), 
with an increased number of abnormal HDSs occurring 
peri‑ and immediately post‑operatively.
Pulmonary artery catheter and transthoracic echocar‑
diography/transesophageal echocardiography
The strength of the relationship between PAC HDSs and 
TTE/TEE assessment was poor [Table 3]. PAC empty 
states only correctly predicted TTE/TEE empty state in 
17/33 (51.5%) measurements, while a normal TTE state 
correlated with a PAC normal state on 29/80 (36.3%) 
measurements. Where echocardiography was normal, 
the PAC suggested an empty state in 39/58 (67.2%) 
measurements. A normal PAC state coincided with an 
empty TTE/TEE state in 10/33 (30.3%) measurements. 
The kappa correlation between echocardiography and 
PAC HDSs was 0.06.
FloTrac/Vigileo™ and transthoracic echocardiography/
transesophageal echocardiography
The strength of the relationship between FV™ and 
echocardiographic states was also poor [Table 4]. The 
overall kappa concordance was 0.14. FV™ predicted the 
normal HDS in 56/83 (67.5%) TTE/TEE measurements, 
Table 1: Patient demographic data (n = 50)
Gender
Male 43 (86%)
Age (years) 69 (41‑90)
ICU length of stay (days) 1 (1‑2)
Ventilation time (h) 9.219 (0‑304)×9.3 (6.1‑12.5
APACHE II 13.5 (6 [3.9]
CABGS only 29 (58%)
AVR only 12 (24%)
MVR only 1 (2%)
CABGS and AVR 8 (16%)
Data are shown as, median (IQR) or n (%). CABGS: Coronary artery bypass surgery, 
AVR: Aortic valve replacement, MVR: Mitral valve replacement, ICU: Intensive 
Care Unit
Table 2: Assessment of hemodynamic state using 
echocardiography, n (%)
TOE 1 
(pre‑CPB)
TOE 2 
(post‑CPB)
Echocardiography 3** (ICU)
Number
Normal 32 (64) 21 (42) 37 (74)
Empty 10 (20) 18 (36) 3 (6)
PSF 5 (10) 2 (4) 3 (6)
Vasodilated 1 (2) 7 (14) 1 (2)
Unavailable 2* (4) 2* (4) 6** (12)
*Not performed as patient unable to have TOE, **TTE unable to be 
interpreted. PSF: Primary systolic failure, TTE: Transthoracic echocardiography, 
TOE: Transesophageal echocardiography, ICU: Intensive Care Unit, 
CPB: Cardiopulmonary bypass
Table 3: Agreement between echocardiography and pulmonary 
artery catheter for predicting hemodynamic state assessed 
using kappa statistics
Echocardiography PAC
Empty Normal PSF Vasodilated Total
Empty 17 10 6 0 33
Normal 39 29 12 0 80
PSF 1 5 3 0 9
Vasodilated 1 5 1 2 9
Kappa concordance 0.057
PAC: Pulmonary artery catheter, PSF: Primary systolic failure
Table 4: Agreement between echocardiography and FloTrac/
Vigileo™ for predicting hemodynamic state assessed using 
kappa statistics
Echocardiography FV™
Empty Normal PSF Vasodilated Total
Empty 12 15 6 0 23
Normal 15 56 11 1 83
PSF 1 4 2 0 7
Vasodilated 2 7 0 0 9
Kappa concordance 0.137
FV™: FloTrac/Vigileo™, PSF: Primary systolic failure
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but only predicted empty in 12/30 (40%) measurements 
and PSF in 2/19 (10.5%) measurements when compared 
to echocardiography.
FloTrac/Vigileo™ and pulmonary artery catheter
There was little relationship between HDSs when 
comparing FV™ and PAC [Table 5]. In particular, in 
this group, there was little correlation in the state of PSF 
between devices.
Primary systolic failure
Both PAC and FV™ tended to over‑report the HDS of PSF 
when compared to echocardiography [Tables 6 and 7]. 
When the HDS was determined as PSF by PAC this 
was confirmed by echocardiography in 2/19 (10.5%) 
measurements and in 3/22 (13.6%) measurements when 
determined by FV™.
Comparison and the “normal” state
Appendix 2 describes the HDSs when compared between 
the 3 devices. PAC and FV™ were comparably more 
reliable in their correlation with PSF states as determined 
by echocardiography (PAC = 3/9, FV™ = 2/7); although, 
numbers in this group were small. Both FV™ and PAC 
tended to over‑record abnormal states when compared 
to echocardiography. When compared with TTE, FV™ 
predicted “normal” states in 56/83 (67.4%) while for PAC 
the rate was 29/90 (32%). The PAC recorded CI <2.2 in 
6/90 (6.7%) readings simultaneously with “normal” TTE’s 
while FV™ recorded 1/90 (1.1%) of these instances. FV™ 
predicted the “normal” HDS in 56 out of 83 “normal” 
patients as determined by echocardiography (67%). PAC 
predicted the “normal” HDS in 29 of 90 “normal” patients 
as determined by echocardiography (32%). At T1, for the 
same patient cohort, 37 abnormal HDSs were suggested 
by PAC (vs. 25 for FV™ and 15 for TEE/TTE).
DISCUSSION
This trial was designed to compare the HDS based on 
information from FV™, echocardiography, and PAC 
in a cardiothoracic surgical population. While overall 
correlation was poor, our data suggest that both FV™ and 
PAC may be useful in acting as triggers for assessment 
of the HDS.
To date, literature on FV™ has reported variable results. 
FV™ has been extensively studied in a number of 
settings. Many of these studies involve earlier software 
iterations,[20,21] or were used in discrete clinical contexts 
such as sepsis[12] or volume expansion.[22] There are few 
studies that are based in the intensive care setting, with a 
percentage error between compared devices of 33% and 
40% suggesting that the use of FV™ in this setting may 
be less reliable.[23] More recent literature is mixed. A study 
of 40 cardiac surgery patients demonstrated percentage 
error rates of up to 61.5%[24] while an error rate of 66.5% 
was demonstrated when comparing FV™ with PAC bolus 
thermodilution in a cohort of 25 cardiac surgery patients.[10]
Recent research using FV™ has focused on absolute 
values rather than the overall HDS[15] and seldom 
using TTE/TEE for comparison.[13] The evidence for the 
accuracy of FV™ data in a variety of clinical settings is 
mixed, although the correlation with invasive monitors 
appears to be improving through software iterations[12,21] 
Questions still remain over the accuracy of FV™ in the 
setting of tachyarrythmias and valvular heart disease;[15] 
although, FV™ has been compared more favorably with 
TTE derived CO measurements when these patients 
groups have been excluded from the study.[13]
Sources of error from previous studies
The accuracy of FV™ in measuring CO under certain 
conditions has been questioned. Suehiro et al. stratified 
three groups according to SVR and demonstrated a 
lower concordance with lower SVR states.[24] This finding 
was reproduced by Sotomi et al. in a cardiac surgery 
population.[25] McLean et al. reported that in critically ill 
Table 5: Agreement between pulmonary artery catheter and 
FloTrac/Vigileo™ for predicting hemodynamic state assessed 
using kappa statistics
FV™ PAC
Empty Normal PSF Vasodilated Total
Empty 11 12 8 1 32
Normal 116 73 14 2 205
PSF 12 8 6 0 26
Vasodilated 1 0 0 0 1
Kappa concordance 0.000
FV™: FloTrac/Vigileo™, PAC: Pulmonary artery catheter
Table 6: Agreement between echocardiography and 
FloTrac/Vigileo™ for predicting hemodynamic state when the 
pulmonary artery catheter cardiac index was below 2.2 L/min/m2 
(primary systolic failure) assessed using kappa statistics
Echocardiography FV™
Empty Normal PSF Vasodilated Total
Empty 4 5 4 0 13
Normal 8 13 3 1 24
PSF 1 0 2 0 3
Vasodilated 0 1 0 0 1
Kappa concordance 0.115
FV™: FloTrac/Vigileo™, PSF: Primary systolic failure
Table 7: Agreement between echocardiography and pulmonary 
artery catheter for predicting hemodynamic state when the 
FloTrac/Vigileo™ cardiac index was below 2.2 L/min/m2 (primary 
systolic failure) assessed using kappa statistics
Echocardiography PAC
Empty Normal PSF Vasodilated Total
Empty 8 2 4 0 14
Normal 5 5 7 0 17
PSF 0 2 2 0 4
Vasodilated 0 0 0 0 0
Kappa concordance 0.17
PSF: Primary systolic failure, PAC: Pulmonary artery catheter
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patients, after the exclusion of patients with irregular 
heart rhythms and aortic stenosis, that FV™ was clinically 
comparable to TTE in CO measurements in critically ill 
patients, and also made the point that multiple paired 
values (from the same patients) used in other studies 
may increase bias. No studies to date have sought to 
compare TTE evaluation of the HDS, or the potential 
clinical decision made, with FV™, or PAC.
The case for hemodynamic assessment
While rates of error may be variable with noninvasive 
monitoring devices, this may not affect the hemodynamic 
decision that is made. We chose to compare HDS rather than 
absolute variables for a number of reasons. Management 
of a patient’s HDS is rarely based on a single parameter, 
but on an overall assessment of the cardiovascular 
system. While in many cases, clear parameters do not 
exist for treatment decisions, a combination of variables is 
frequently used to interpret and act on the HDS. We have 
taken a pragmatic view of this decision‑making in tandem 
with proprietary suggestions regarding monitoring values, 
and Australasian practice. TTE is performed regularly 
on patients who have acute hemodynamic disturbance 
and algorithms exist for emergent interpretation of the 
HDS (e.g., RACE, H.A.R.T.scan®). A difference in variables 
has less clinical significance or impact if it does not alter 
treatment. It has been suggested that the use of PACs does 
not alter outcomes in large critical care populations,[3] and 
that the introduction of FV™ has not been associated with 
increased mortality.[26] Data supporting the safety of FV™ 
come from Kirton et al., who demonstrated no significant 
change in mortality over 5 years period of change from 
PAC to FV™ monitoring in a surgical intensive care 
population. Therefore, we designed the trial to assess 
the clinically relevant endpoint of HDS, rather than 
performing further measurements. Our trial examined 
hemodynamic data which may represent decision points 
in the postoperative setting (e.g., empty = fluid therapy, 
vasodilated = vasopressor, and PSF = inotrope).
Potential for decreased intervention
Our data is consistent with previous studies, with a poor 
absolute correlation between devices, and a tendency for 
noninvasive monitors to over‑record abnormal HDSs 
when compared to PAC/echocardiography.[10,14,21,27,28] 
An important role of any monitoring device is to guide 
the clinician as to when no intervention is required. 
Monitoring devices may promote active management if 
staff react to abnormal parameters. This trial showed a 
large potential difference in active intervention between 
the 3 hemodynamic assessment modalities and that a less 
interventional style of management may be enhanced by 
the use of TEE/TTE.
Strengths
Our trial was a pragmatic design, and was the first 
to utilize algorithmic echocardiography to determine 
the HDS in comparison to two monitoring devices 
(PAC and FV™). Efforts were made to ensure a standardized 
system of measurement (modified H.A.R.T.scan® 
criteria, practice‑based monitoring parameters) and 
standardization (all TTE/TEE practitioners had completed 
PTEeXAM®/H.A.R.T.scan®/PGDipCU).
All TEE/TTEs performed were independently evaluated 
by practitioners who were blinded to the monitoring data. 
“Normal” values for FV™ and PAC can be disputed; 
however, proprietary guidelines were used where 
possible, in tandem with unit practice. Several studies 
have shown a lack of correlation between PAC and 
FV™.[10,27,28] This trial allowed a third hemodynamic 
assessment modality to be applied in order to assess 
which device is more representative of the HDS.
We targeted the main HDSs which lead to intervention 
perioperatively in the cardiothoracic patient population,[29] 
with measures of preload, afterload, and contractility. We 
used simple, reproducible, echocardiographic definitions 
with parameters which have been studied in critical care.[16]
Limitations
This was a small, observational trial, which contained a 
small number of patients with abnormal HDSs. Patients 
with poor ejection fractions (<20%) were not evaluated 
as a separate patient population.
Although blinding was maintained at the time of data 
collection, the timing of the devices is not uniform. FV™ 
updates the CO approximately every 20 s while a Vigilance 
II™ monitor averages readings over a longer time duration, 
and average values can be delayed by several minutes. 
Limited TTE/TEE may take several minutes to perform. 
These circumstances are similar to the real practice of 
intensive care, which frequently evolves the performance 
of a TTE/TEE several minutes after being triggered by a 
PAC/FV™ reading. Measurements in the trial were taken, 
as far as reasonably possible, simultaneously.
While the algorithm for HDSs was constructed to 
mirror local practice and evidence base as closely as 
possible [Appendix 1] this may not reflect practice in all 
sites. Many sites do not consider CVP in assessment of the 
HDS, and there is no broad consensus as to interpretation 
of this variable. In addition, no assessment of right 
heart function was undertaken. Right heart function 
may influence both CVP and cardiac performance. 
CVP remains a commonly measured and utilized 
measurement in the perioperative care of the cardiac 
surgery patient, in a manner that is reflective in the 
pragmatic design of this trial.[17]
While efforts were made to standardize TTE/TEE performance 
and measurement, different techniques, patient habitus, 
and echo windows introduce variability, which is reflected 
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in the actual practice of critical care echocardiography. 
A number of TTEs were technically difficult, which mirrors 
the cardiothoracic postoperative population.
CONCLUSIONS
In this trial, FV™ and PAC were shown to agree poorly 
with TTE/TEE assessment of the HDS in an adult 
cardiothoracic population. Agreement between the FV™ 
and PAC was also poor. Caution is recommended in 
interpreting isolated hemodynamic monitoring data. All 
hemodynamic monitoring devices have inherent sources 
of error. Caution is advised in interpreting any single 
device or measurement as a gold standard. We suggest 
that hemodynamic measuring devices such as FV™/PAC 
may act as triggers for a global hemodynamic assessment 
including consideration of TTE/TEE.
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Appendix 1: Hemodynamic states for echocardiography, pulmonary artery catheter, and FloTrac/Vigileo™
Echocardiography PAC FV™
Normal FS: 28%‑44%
FAC: 505‑65%
LVEDD: 3‑5.6 cm
LVEDA: 8‑14 cm
CVP ≥12 mmHg
CI >2.2 L/min/m2
SVRI >1970 dynes.s.cm−5
SVV ≤13%
CI >2.2 L/min/m2
SVRI >1970 dynes.s.cm−5
Empty IAS mid systolic buckle/LVEDD <3 cm/LVEDA <8 cm2 CVP <12 mmHg SVV ≥13%
PSF FS <28%
FAC <50%
CI <2.2 L/min/m2 CI <2.2 L/min/m2
Vasodilated FS >44% (FAC >65%) + normal LAP SVRI <1970 dynes.s.cm−5 SVRI <1970 dynes.s.cm−5
SVV: Stroke volume variation, IAS: Intra atrial septum, LVEDD: Left ventricular end diastolic diameter, LVEDA: Left ventricular end diastolic area, FS: Fractional 
shortening, FAC Fractional area change, LAP Left atrial pressure, CI: Cardiac index, PSF: Primary systolic failure, SVRI: Systemic vascular resistance index, CVP: Central 
venous pressure, FV™: FloTrac/Vigileo™, PAC: Pulmonary artery catheter
Appendix 2: Hemodynamic state data
Patient number EHDS #1 PACHDS #1 FV™ HDS #1 EHDS #2 PACHDS #2 FV™ HDS #2 EHDS #3 PACHDS #3 FV™ HDS #3
1 N E N N N E N
2 N PSF E E E E E N
3 N N N N N N N E N
4 N PSF E N E N N
5 N E PSF PSF E N N E N
6 PSF N PSF N N E N
7 N N N N N N N
8 E N E E PSF N N PSF
9 N E PSF V N N N E N
10 N E N E N N V V E
11 N PSF N N N N N N N
12 N PSF E N E N
13 PSF PSF PSF V N N N E N
14 N N N E N
15 N E N N E N E E N
16 PSF PSF PSF E PSF PSF E N N
17 V V N E N E N E N
18 E E PSF E E N E N N
19 N PSF PSF V N N N E E
20 E PSF PSF N E N N E N
21 PSF N N N N N N N N
22 N E PSF E E E N N E
23 N E N PSF N N
24 N E N N PSF N PSF PSF E
25 N E PSF N E N N N E
26 E E N E PSF N E PSF N
27 E E E E N N N N E
28 N E V V N N N N N
29 N E N E E N N E N
30 N E N N E N N E N
31 N E E N E E PSF N N
32 N PSF E E N E N N N
33 E E PSF E E N N N N
34 N E N V PSF N N E N
35 N N N V N E N N N
36 PSF N E N N
37 N E N V E N N N N
38 N E N N E N N E
39 N PSF E N PSF N N N N
40 N N N E N E N N
41 N PSF E N PSF N N E N
42 N N PSF N N PSF N N PSF
43 N N N E E PSF N N E
44 V N
45 E PSF E E N E N E PSF
46 E E E N N N N N PSF
47 N PSF N N N N
48 E E E E E N N E N
49 E E E E PSF E N E N
50 E E E N N N N E N
EHDS: Echocardiography hemodynamic state, PAHDS: Pulmonary artery catheter hemodynamic state, FV™HDS: Flo Trac/Vigileo™ hemodynamic state, E: Empty, 
N: Normal, V: Vasodilated
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